Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-MP + TMZ in Recurrent Glioblastoma
NCT06279767Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mercaptopurine in glioblastoma (GBM), sponsored by Jiangsu Provincial People's Hospital. Started Jul 2022; status: recruiting.
02
Drugs
mercaptopurine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT06279767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06279767.